IL6 and COVID-19: In addition, another even larger meta-analysis on over 13,000 participants recruited in 77 observational studies has demonstrated a role of the circulating level of cytokines (i.e., IL-6) in predicting severity and mortality in those diagnosed with COVID-19 [7], further underscoring a detrimental prognostic role of inflammation.